China Emerges as Top Competitor in Humanoid Robot Race Tesla CEO Elon Musk Says Stock Futures and Bond Yields Decline After Reports of Putins Updated Nuclear Doctrine EasyJet FirstHalf Losses Widen as Iran Conflict Drives Up Fuel Costs and Weighs on Bookings ICON plc Schedules Q4 and FY2025 Earnings Call Discloses Nasdaq Deficiency Notice Plus500 Reports 11 Quarterly Revenue Increase Maintains FullYear Outlook Europe Risks AI Dependency Trap as Tech Dominance Shifts to US and Asia Report Warns Aditxt Inc ADTX Q3 2025 Earnings Significant Loss Per Share and No Revenue Amid Sharp Stock Decline ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss LOAR Q1 2026 Earnings Massive EPS Beat Signals Strong Execution Revenue Data Not Reported TSQ Q1 2026 Earnings EPS Misses Estimates Amid Challenging Ad Environment Sound Point Meridian Capital Inc Q1 2026 Earnings Earnings Miss as EPS Falls Short of Estimates ADAML Q1 2026 Earnings Preferred EPS Crushes Estimates by 75 as FixedtoFloating Rate Structure Gains Traction Genmab ADS Slips Amid Market Caution Key Support Levels in Focus Insight Digital Partners II Units DYORU Hovers Near Support Amid Modest Decline KNRX Faces Pressure Knorex Ltd Tests Key Support Levels After 263 Decline AXIL Brands Inc AXIL Modest Decline Near Key Support Levels at 703 Albany International AIN Holds Steady Near Support as Technical Picture Remains Mixed Micron Technology MU Slips 146 as Bullish Momentum Fades Near 750 ISSC Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher BSAC Q1 2026 Earnings EPS Surpasses Estimates but Stock Ticks Lower JLL Q1 2026 Earnings Solid EPS Beat Amid Cautious Market Sentiment MetroCity Bankshares Inc MCBS Q1 2026 Earnings EPS Beats Estimates by Nearly 5 Shares Falter FBRX Q1 2026 Earnings WiderthanExpected Loss Reflects PreRevenue Biotech Reality 3M India Announces 506 Special Dividend and Reports 202 Profit Surge for Q4 FY26 Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue Whitehawk Therapeutics WHWK Edges Lower as Stock Hovers Near Key Support